The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
Final survival results from SPARTAN, a phase III study of apalutamide (APA) versus placebo (PBO) in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC).
 
Eric Jay Small
Stock and Other Ownership Interests - Fortis; Harpoon Therapeutics
Honoraria - Janssen
Consulting or Advisory Role - Beigene; Fortis; Janssen Oncology; Teon Therapeutics; Tolero Pharmaceuticals
Research Funding - Janssen (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Janssen
 
Fred Saad
Honoraria - Abbvie; Amgen; Astellas Pharma; AstraZeneca; Bayer; Janssen Oncology; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca/MedImmune; Bayer; Janssen Oncology; Sanofi
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Pfizer (Inst); Sanofi (Inst)
 
Simon Chowdhury
Honoraria - Clovis Oncology; Novartis
Consulting or Advisory Role - Astellas Pharma; Bayer; Clovis Oncology; Janssen-Cilag; Pfizer
Speakers' Bureau - Pfizer
Research Funding - Sanofi/Aventis (Inst)
 
Stephane Oudard
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; IPSEN; Janssen; Merck; MSD; Novartis; Pfizer; Roche/Genentech; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; IPSEN; Janssen; Merck; MSD Oncology; MSD Oncology; Novartis; Pfizer; Roche; Roche; Sanofi
Research Funding - Ipsen; Sanofi
Travel, Accommodations, Expenses - Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Merck; MSD Oncology; Novartis; Pfizer; Roche
 
Boris A. Hadaschik
Consulting or Advisory Role - Bayer; Janssen; Lightpoint medical
Research Funding - Janssen
Patents, Royalties, Other Intellectual Property - Uromed
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Janssen
 
Julie N Graff
Honoraria - Astellas Medivation; Bayer; Bayer; Bayer; Janssen Oncology; Janssen Oncology; Janssen Oncology; Janssen Oncology; Sanofi; Valeant/Dendreon
Consulting or Advisory Role - Exelixis
Speakers' Bureau - i3 CME
Research Funding - Janssen Oncology (Inst); Medivation (Inst); Merck Sharp & Dohme (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Oncoresponse: Exceptional responders
Travel, Accommodations, Expenses - Bayer; Clovis Oncology; Merck Sharp & Dohme; Merck Sharp & Dohme; Sanofi
 
David Olmos
Honoraria - Astellas Pharma (Inst); Bayer; Janssen
Consulting or Advisory Role - AstraZeneca (Inst); Bayer; Bayer (Inst); Clovis Oncology; Janssen; Janssen (Inst)
Research Funding - Astellas Medivation (Inst); AstraZeneca (Inst); Bayer (Inst); Genentech/Roche (Inst); Janssen (Inst); Pfizer (Inst); Tokai Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Ipsen; Janssen
 
Paul N. Mainwaring
Employment - Xing Technologies
Leadership - Xing Technologies
Stock and Other Ownership Interests - Xing Technologies
Honoraria - Ipsen; Janssen Oncology; Medivation/Astellas; Merck; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - Janssen Oncology; Pfizer
Speakers' Bureau - AstraZeneca; Ipsen; Janssen Oncology; Medivation/Astellas; Merck; Novartis; Pfizer; Roche/Genentech
Research Funding - Merck KGaA
Patents, Royalties, Other Intellectual Property - 4 patents on nanotechnology
Travel, Accommodations, Expenses - Ipsen; Janssen Oncology; Medivation/Astellas; Merck; Novartis; Pfizer; Roche/Genentech; Xing Technologies
 
Ji Youl Lee
No Relationships to Disclose
 
Hiroji Uemura
Honoraria - Astellas Pharma; Bayer Yakuhin; Janssen Oncology; Sanofi; Takeda
 
Peter De Porre
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Andressa Smith
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
Patents, Royalties, Other Intellectual Property - I am co-authors in several patents
Travel, Accommodations, Expenses - Janssen Research & Development
 
Sabine Doris Brookman-May
Employment - Janssen Research & Development
Leadership - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Susan Li
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Ke Zhang
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
Research Funding - Janssen Research & Development
Travel, Accommodations, Expenses - Janssen Research & Development
 
Oliver Brendan Rooney
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Angela Lopez-Gitlitz
No Relationships to Disclose
 
Matthew Raymond Smith
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Janssen Oncology; Lilly; Novartis; Pfizer
Research Funding - Bayer (Inst); Gilead Sciences (Inst); Janssen Oncology (Inst); Lilly (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Janssen; Lilly